FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

15512111000001104: Feminax Ultra 250mg gastro-resistant tablets (Bayer Plc) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
54813101000001114 Feminax Ultra 250mg gastro-resistant tablets (Bayer Plc) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
54813201000001119 Feminax Ultra 250mg gastro-resistant tablets (Bayer Plc) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Feminax Ultra 250mg gastro-resistant tablets (Bayer Plc) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Feminax Ultra 250mg gastro-resistant tablets (Bayer Plc) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Feminax Ultra 250mg gastro-resistant tablets (Bayer Plc) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Feminax Ultra 250mg gastro-resistant tablets (Bayer Plc) Is a Product containing precisely naproxen 250 milligram/1 each gastro-resistant oral tablet true Inferred relationship Existential restriction modifier
Feminax Ultra 250mg gastro-resistant tablets (Bayer Plc) Has active ingredient Naproxen false Inferred relationship Existential restriction modifier
Feminax Ultra 250mg gastro-resistant tablets (Bayer Plc) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Feminax Ultra 250mg gastro-resistant tablets (Bayer Plc) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Feminax Ultra 250mg gastro-resistant tablets (Bayer Plc) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Feminax Ultra 250mg gastro-resistant tablets (Bayer Plc) Has excipient Lactose false Inferred relationship Existential restriction modifier
Feminax Ultra 250mg gastro-resistant tablets (Bayer Plc) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Feminax Ultra 250mg gastro-resistant tablets (Bayer Plc) Is a Feminax Ultra true Inferred relationship Existential restriction modifier
Feminax Ultra 250mg gastro-resistant tablets (Bayer Plc) Has specific active ingredient Naproxen true Inferred relationship Existential restriction modifier
Feminax Ultra 250mg gastro-resistant tablets (Bayer Plc) Has dispensed dose form Gastro-resistant oral tablet true Inferred relationship Existential restriction modifier
Feminax Ultra 250mg gastro-resistant tablets (Bayer Plc) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Feminax Ultra 250mg gastro-resistant tablets (Bayer Plc) 9 tablet Has AMP True Feminax Ultra 250mg gastro-resistant tablets (Bayer Plc) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start